Peripheral Neuropathy Trial, Recruiting NCT06653543 Sponsor: Cairo University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06653543
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cervical radiculopathy (a condition involving nerve irritation in the neck).
  • People between the ages of 20 and 60 years old.
  • People experiencing pain that radiates down one arm along the path of the median nerve.
  • People who test positive on a specific physical assessment called the Upper Limb Tension Test 1 (ULTT 1), which checks for nerve sensitivity in the arm.
  • People of any gender, male or female.
  • People who are able to understand instructions and are willing to take part in the study.

Who may not be able to join:

  • People who have a history of trauma, dislocation, or partial dislocation of the arm or shoulder.
  • People who have Rheumatoid Arthritis (an inflammatory joint condition).
  • People who have been diagnosed with any form of cancer.
  • People who have narrowing of the spinal canal (spinal canal stenosis).
  • People who have cervical instability or a condition where spinal bones have slipped out of position (spondylolisthesis).
  • People who have reduced blood flow through certain arteries that supply the brain (vertebral-basilar insufficiency).
  • People whose arm pain is related to reduced blood flow to the heart (cardiac ischemia).
  • People who have had surgery on the neck or mid-back (cervical or thoracic spine).
  • People whose nerve symptoms are caused by a systemic condition such as diabetic nerve damage.
  • People who have had a recent fracture or surgery in or around the shoulder.
  • People who have carpal tunnel syndrome.
  • People who have thoracic outlet syndrome (a condition where nerves or blood vessels are compressed near the collarbone).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 201013863820

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 March 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

median nerve conduction study

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov